Why the ‘molecular scissors’ metaphor for understanding CRISPR is misleading
By Naomi Schalit,
The Conversation
| 07. 04. 2019
Last week I read an article about CRISPR, the latest tool scientists are using to edit DNA. It was a great piece – well researched, beautifully written, factually accurate. It covered some of the amazing projects scientist are working on using CRISPR, like bringing animals back from extinction and curing diseases. It also gave me the heebies, but not for the reason you might expect.
My unease was the echo of a feeling I’d had during the early days of my PhD, when some fellow malaria researchers made a discovery that was reported on the news. I was thrilled for them, but I understood the incremental nature of the work they were doing. I knew that in a real-world, drugs-in-the-clinic sense, we were no closer to a breakthrough than we’d been the day before. I thought the reporters had communicated that clearly. Five minutes later my Dad called to ask if I was out of a job, and what I was going to do now that malaria was cured.
I don’t pretend to understand all the myriad reasons for the...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...